<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">Primary antiphospholipid syndrome</z:e> (APS) is characterized by venous or arterial thrombotic events and/or <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent abortions</z:e>, fetal <z:hpo ids='HP_0011420'>death</z:hpo>, preeclasmpsia, <z:hpo ids='HP_0100601'>eclampsia</z:hpo> in the presence of anticardiolipin antibodies or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, in the absence of accompanying diseases </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> can activate endothelial cells, and were recently implicated in <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>To assess potential endothelial impairment and early signs of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, flow-mediated (endothelium-dependent) and nitrate-mediated (endothelium independent) vasodilation, as well as <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor antigen level and carotid artery intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) were measured in patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> and in healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>Flow-mediated vasodilation in patients with primary APS was significantly lower than that of controls (3.43 +/- 2.86% versus 7.96 +/- 3.57%; P &lt; 0.0001) </plain></SENT>
<SENT sid="4" pm="."><plain>We also found significantly higher <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> antigen levels in patients with primary APS than in the control group (157.91 +/- 52.45% versus 125.87 +/- 32.8%; P = 0.012) </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, carotid artery <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was significantly larger in the primary APS group compared to controls (0.714 +/- 0.2 mm versus 0.58 +/- 0.085 mm; P = 0.0037) </plain></SENT>
<SENT sid="6" pm="."><plain>Our results reflect ongoing endothelial damage and <z:hpo ids='HP_0004943'>accelerated atherosclerosis</z:hpo> in patients with primary APS, and suggest that vasoprotective therapy may be beneficial in the treatment of these patients </plain></SENT>
</text></document>